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Investigating the Role of Transcription Factor AP-2y in Reproduction
Abstract
The proper formation of gametes is critical for the propagation of species and for the
fertility of the individual. The molecular pathways involved in gamete formation remains
elusive, therefore, identification of genes involved is an important prerequisite to further
our understanding of reproduction. This research will improve infertility treatments and
prevention methods in animals and human s. We created mutants that lacked AP-2y
transcription factor after the mouse had entered meiosis and initiated folliculogenesis.
The AP-2y mutants were still fertile and phenotypically similar to normal mice that
expressed AP-2y transcription factor. We also produced mutants that lacked AP-2y
transcription factor during embryonic development at embryonic day 6.5. The se mutants
resulted in disrupted formation of primordial germ cells, during development. There were
no germ cells present in AP-2y mutants. This data shows that AP-2y transcription factor
is needed during embryonic germ cell development

and may be involved in the

migration, differentiation, and production of primordial germ cells.
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Introduction
The AP-2 transcription factors
Transcription factors (TF) function to regulate genes by either up regulating or depressing
expression of targeted genes. One family of transcription factors is the five-member AP2 transcription factor family. The AP-2 TF family consists of 52 kDa proteins AP-2a,
AP-2~, AP-2y, AP-28 and AP-2£ (Eckert et al., 2005).
AP-2 TF family orthologs can be found in many species including, Xenopus, fish,
chickens, rats, mice and humans (Auman et al., 2002; Bauer et al., 1994; Bauer et al.,
1998; Knight et al., 2005; Luo et al., 2002; Monge et al., 2001). TF proteins contain
different domains for protein dimerization, DNA binding, and transcriptional activation.
In mammals, all AP-2 proteins except AP-28 are encoded for by seven exons and share
characteristic domain structure (Eckert et al., 2005; Williams and Tjian, 1991). All
members of the AP-2 TF family share a conserved helix-span-helix DNA binding
dimerization motif at the carboxyl terminus. This region consists of two amphipathic ahelices separated by a ~80 amino acid span that plays a role in DNA binding and protein:
protein dimerization. The AP-2 transcription factors are able to form protein hetero- and
homodimers using this region (Williams and Tjian, 1991). Similar helix-span-helix
(HSH) motifs can be found in other DNA binding proteins myoD, E12, TFE2 and achaete
scute daughterless (Duan et al., 1995; Gaubatz et al., 1995; Newman et al., 2001). The
AP-2 HSH region is sufficient for protein dimerization but a downstream basic region of
the protein is necessary to act with this region to complete DNA binding (Williams and
Tjian, 1991). The highly conserved C-terminus HSH and centrally located basic region
enable AP-2 proteins to recognize and bind G/C rich sequences in DNA to bind,
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specifically the pallindromic consensus sequence 5'-GCCN 3GGC-3' which can be found
in various enhancer sequences (Hilger-Eversheim et al., 2000). Transactivation of genes
is achieved by a less conserved praline and glutamine rich domain at the amino terminus
in AP-2 proteins (Eckert et al., 2005). This region yields the variability seen in the AP-2
family members when binding target genes and activating processes such as cell growth
and differentiation. The similarity in the AP-2 family members suggests that these
proteins could be playing redundant roles as well as individual roles. The AP-2 genes
have been implicated in regulating genes necessary for cell fate determination pathways
such as proliferation , differentiation and apoptosis (Hilger-Eversheim et al., 2000;
lmagawa et al., 1987; Luscher et al. 1989).
Since AP-2y was identified in Pl 9 carcinoma cells, multiple other types of cancer cells
have shown AP-2y expression suggesting that the misexpression of this transcription
factor may lead to abnormal cell states by aberrantly inducing proliferation or
differentiation (Friedrichs et al., 2005; Hoi-Hansen et al., 2004; Hong et al., 2005; Jager
et al., 2005). Elevated levels of both AP-2a and AP-2y have been reported in the 25-30%
of breast cancers that exhibit elevated levels of the critical regulatory proto-oncogene cerbB-2 (Bosher et al., 1996; Li et al., 2002). In breast carcinomas, research shows that
AP-2a,

~

and y are capable of binding the c-erbB-2 promoter as hetero or homodimers

and up regulate expression of c-erbB-2 (Bosher et al., 1996). Abundant amounts of the
AP-2y transcript have also been identified in testicular germ cell tumors (Hoei-Hansen et
al., 2004). AP-2y expression is regulated by retinoic acid in testicular carcinomas as
well, further indicating the importance of retinoic acid in regulating expression of AP-2y
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(Hoei-Hansen et al., 2004; Kopan and Fuchs, 1989). The presence of AP-2y in tumors
suggests that it may play a vital role in regulating proliferation of cell populations.
Study of AP-2y in the embryos by a traditional gene knockout has detected a lethal
phenotype. AP-2y mutants fail on embryonic day 7.5 (E7.5) from failure of the embryos
to implant caused by defects in the extraembryonic tissues (Auman et al., 2002) (Winger
et al., 2006).

Primordial germ cells in the developing gonad
Germ cells are first specified from a pool of proximal epiblast cells that will migrate,
proliferate, populate the gonad, undergo meiosis and result in specialized gametes for
their ultimate role in reproduction-successful fertilization. The primordial germ cells
migrate by amoeboid movement from the proximal epiblast towards the primitive streak
and then up into the embryonic gonad termed genital ridge. It will eventually form the
gonads and any primordial cells that do not reside in genital ridge will be degenerated. As
primordial germ cells are colonizing the genital ridges, they are undergoing mitosis and
their numbers increase significantly (the growth number is dependent upon genetic
regulation of proliferation and survival rates of PGCs).

After populating the genital

ridge, in the female, they differentiate into primordial follicles which are diploid oocytes
surrounded by a single layer of squamous follicular cells. The oocyte is considered
primary because it has yet to carry out meiosis division I. Before birth, the diploid
primary oocytes enter a final round of DNA synthesis and are then arrested in prophase I
of the first meiotic division until shortly before ovulation; thus, a primary oocyte may
remain in prophase I for most of a female's reproductive life. The reproductive program
required in the development of the gonad requires the coordinated expression of several
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genes necessary to control these events. Several gene mutation studies have resulted in
models of reproductive failure and many are genes involved in regulation of germ cells
(McLaren, 2003; Rajkovic et al., 2004). We have discovered that a gene mutation in the
transcription factor AP-2y prevents germ cell development.
Folliculogenesis and spermatogenesis
Folliculogenesis is the process where ovarian follicles develop from primary into
secondary and eventually into antral follicles that become eligible for ovulation.
Ovulation is the process in the estrus cycle by which a mature ovarian follicle ruptures
and discharges the oocyte. Folliculogenesis is initiated at birth and first ovulation is at
puberty. (Senger, 2003). The genes involved in maintenance of folliculogenesis remain
elusive. There are many genetic diseases, such as familial ovarian failure and
galactosaemia that cause early ovarian failure in woman. Understanding the molecular
pathways involved in folliculogenesis maintenance could help us discover preventative
methods for young woman and animals that are faced with premature ovarian failure.
Spermatogenesis takes place within semineferous tubules. It is the process where
spermatozoa are formed, consisting of proliferation (mitosis), meiosis and differentiation.
It starts at puberty and usually continues uninterrupted till death (Senger, 2003).

AP-2y expression in the gonads
AP-2y transcripts have been detected using RT-PCR at embryonic day (E) 12.5,
13.5, 14.5, and 18.5 in both male and female gonads (Fig 1).
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In addition, AP-2y is present in the ovary as
detected by RT-PCR . The location of AP-2y
rnRNA within the adult ovary was detected by
in situ hybridization , and is definitely in the

Testis

oocyte but also is expressed in the granulosa
cells surrounding the oocyte.

Figure 1, AP-2y mRNA in fetal
gonads. RT-PCR detection of mRNA in
male and female gonads.

Potential role of AP-2y in the gonad
To determine the role of AP-2y in the ovary, it

was necessary to use a conditional mutation because a traditional gene KO resulted in an
early lethal phenotype. Therefore, to study the mutation in the adult ovary Cre-loxP
technology was used. The Cre-loxP technology was derived from the Pl bacteriophage.
The Cre protein is a recombinase that recognizes a 34-bp sequence called a loxP site. Cre
recombinase is expressed in a tissue specific manner to detect a floxed portion of the AP2y gene and delete that portion of the DNA. The term "floxed" refers to a gene that
contains a functionally important coding region of a gene bracketed by 2 loxP sites. The
loxP sites forces the site of specific deletion of this critical portion of the allele when Cre
recombinase is expressed (Fig 2). A mouse that contains loxP sites bracketing exon 6 of
the AP-2y gene has been created and in the absence of Cre are viable and fertile proving
that the floxed or conditional AP-2y allele is functional. The effectiveness of Cre deletion
has also been demonstrated and is verified by PCR using specific primers that detect

6

different bands for the floxed allele, for the Cre deleted allele, and for the wild type
allele.

loxP site -

l7

....---......_
-.
AP-2y floxed allele
.~

-

.,__,____.
_. _ .

AP-2y deleted allele
( after Cre Exposure)
Figure 2, Loss of function mutation of AP-2y achieved by Cre recombinase

The More-Cre mouse expresses Cre in the epiblast at E6.5 and therefore mutates AP-2y
in the entire embryo while leaving the trophoblast lineage intact, to bypass the lethal
mutation and produce mice that are adult AP-2y mutants. Majorities of these mutant mice
are born healthy and survive through adulthood. They are fertile when they first reach
maturity. However, the common adult female phenotype is for the reproductive
productivity to drop off beginning around 5 months of age with complete infertility often
observed around 7 months. The infertility in these animals is due to the failure of the
ovaries to produce follicles. This is illustrated by histological sections of ovaries that
show the number of follicles in the mutant ovaries that are greatly decreased and often
entirely absent (Fig 3). The premature ovarian failure is perhaps a result of a reduced
number of germ cells.
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Figure 3, Comparison of follicle production in ovaries from mice at
7 months of age. The ovary on the left is a wild-type which contains
several large follicles. The ovary on the right is an AP-2y mutant which
is completely lacking follicles

This result does confirm a reproductive phenotype; however the More-Cre deletion is not
complete in the gonad . It appears to be the case in the adult female because the mice that
contained the More-Cre, AP-2y null allele, and an AP-2y floxed allele were mated to wild
type males and were unable to produce any offspring that contained a recombined floxed
allele. This same result was detected in males .
Therefore, to further investigate the hypothesis that AP-2y plays a role in gamete
formation, we wanted to create a conditional mutation in adults to study the role of AP-2y
during folliculogenesis and spermatogenesis. Moreover, we want to use a conditional
mutation with complete recombinase activity. If our mice become infertile, with no sperm
or eggs present, it illustrates that AP-2y is involved in differentiation of germ cells, or in
gamete formation after folliculogenesis and spermatogenesis has been initiated.
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Materials and Methods
Producing adult AP-2y knockout mice
ERTM-CRE mice were purchased from Jackson labs and these mice will be expressing
AP-2y until induced to produce the AP-2y mutation. This commercially available mouse
contains a fusion protein between the Cre and the mutated form of the ligand binding
domain of the estrogen receptor (Cre-ER tm*). The mutated receptor is no longer
capable of binding its natural ligand (17b-estradiol) but will bind to, and can be induced
by, exogenously injected tamoxifen (TM). This gene is ubiquitously expressed, driven by
the ~-actin promoter, but the recombinase protein is sequestered to the cytoplasm by
Hsp90 and unable to enter the cell nucleus and cleave the DNA. Binding of TM by the
ERTM receptor removes the Hsp90 and allows the active Cre into the nucleus (Hayashi
et. al., 2002). ERTM-Cre mice were mated to female mice that were homozygous for AP2y floxed allele. ERTM-Cre and AP-2y null genotypes of mice in the breeding colony
were determined using polymerase chain reaction (PCR) performed on tissues. For timed
pregnancies, specific matings were set up in the afternoon, and the mice were checked for
vaginal plugs in the morning.

Producing AP-2y knockout fetuses
Sox2Cre mice were purchased from Jackson labs and Cre recombinase activity is
restricted to the epiblast The Cre recombinase gene sequence is regulated by a 12.5 kb
upstream regulatory sequence from the Sox2 gene, wherever there is up regulation of the
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Sox2 gene, Cre recombinase will also be expressed, producing a targeted gene deletion in
these cells. Sox2Cre is expressed in epiblast cells, which means that gene recombination
of a target gene, will take place only in the embryonic po1tion of conceptsus allowing the
placental tissues to develop with normal gene expression. Sox2-Cre recombinase is
activated at E6.5 (Hayashi et al., 2002).
Sox2-Cre mice were mated to female mice that were homozygous for AP-2y floxed
allele. Sox2-Cre, AP-2y null and AP-2y flox genotypes of mice in the breeding colony
were determined using polymerase chain reaction (PCR) performed on tissues. For timed
pregnancies, specific matings were set up in the afternoon, and the mice were checked for
vaginal plugs in the morning .

Genotyping Mice
The presence of ERTM-Cre or Sox2-Cre transgene, AP-2y null and AP-2y flox alleles
were determined using PCR. For the Sox2-Cre experiment, fetuses were dissected from
the sacrificed mother at E16.5 and El8.5 , and tail samples from the fetuses were
collected and placed in lysis buffer containing proteinase K for tissue homogenation.
For the ERTM-Cre experiment, tail samples were collected from 3 week mice and placed
in lysis buffer containing proteinase K for tissue homogenization . In addition , after the
mice were injected with tamoxifen, PCR determined AP-2y flox deletion. PCR reactions
to detect these genes were carried out for 35 cycles (94°C, 40 sec; 67°C, 40 sec; 72°C, 40
sec) in a buffer containing: .2mM of each dNTP, lµM of each primer, 1 µM Taq DNA
polymerase (Fermentas, Hanover, MD) 4mM MgCb and approximately lµg genomic
DNA. Following thermocycling, product was loaded on a 2% agarose gel containing

ethidium bromide and run for lhour at 110 V. PCR product was visualized using UV
light transillumination.
Primer Sequences:

CRE primers
Cre 1 F- 5' - GCT GGT TAG CAC CGC AGG TGT AGA G - 3'
Cre 1 R - 5' - CGC CAT CCT CCA GCA GGC GCA CC - 3'
AP-2y KO primers
Neo 3 KO - 5' -AAC GCA CGG GTG TTG GGT CGT TTG TTC G - 3'
Xgamma 3 - 5' - CCT TCT GCT CTC TGG CCT CCT TGC AGC C - 3'
Gamma WT 5 - 5' -TCA TGG CTT TGG CAG CCA GGC CAT C - 3'
AP-2y flox deleted primers
GamXbSq F-5'-GAG TTA GAG AGC AAG TTA CAG GCT G-3'
GamSq3 R-5'-CTT GGA ACT CAC TTT GTA GCT GAG G-3'
Injections of ERTM-Cre adult mice
Tamoxifen was dissolved in corn oil at a concentration of lOmg/ml. TM was injected
intraperitoneally into adults at 3mg per 40 g of body weight every other day for 6 days.
Then 3-4 months later, mice were reinjected, at 9mg per 40 g of body weight for 5
consecutive days, or a single injection at 9mg per 40 g of body weight for 5 consecutive
days with TM dissolved in l 5mg/ml of corn oil was used.

BrdU immunohistochemistry
Bromodeoxyuridine (5-bromo-2deoxyuridine,

BrdU) is a synthetic nucleoside that is an

analog of thymidine. Brdu is commonly used in detection of proliferating cells in living
culture. BrdU was dissolved in phosphate-buffered saline at 3µg/ml and two injections of
BrdU (50µg/g of body weight) and was administered intraperitoneally into male mice 1
hour apart . Mice were euthanizedl hour after the second injection (Wang and Hardy,
2004).
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lmmunochemistry was performed on testes that were subjected to BrdU. Testes were
embedded in paraffin and sectioned in Sµm thick sections. Slides were deparaffinized,
and incubated for 10 minutes in 3% H202 in PBS to block endogenous peroxidase
activity. Slides were thoroughly rinsed in Tris-buffered saline with tween 20(TBST).
Slides were then boiled for 10 minutes in working solution BDtm Retrievagen A, and
allowed to cool to room temperature. Biotinylated anti-BrdU antibody 1: 10 in TBST and
slides were incubated for one 1 hour. Next, Streptavidin-HRP was applied to each slide
and incubated for 30 minutes. Then DAB substrate solution (prepared by adding 1 drop
of DAB chromogen to 1 ml of DAB buffer) was applied and incubated for 5 minutes.
Slides were counterstained in hematoxylin for 15 seconds and rinsed thoroughly with
water. Slides were dehydrated and visualized at 20X or 40X using an Olympus BX40
microscope.

Histology and oocytes counts for adult AP-2y mutant ovaries
Ovaries were fixed, paraffin-embedded and serially sectioned at Sµm. Serial sections
were stained with hemotoxylin and eosin, and every sixth slide was counted. The average
number of oocytes per section was calculated and significant differences in oocytes
numbers between mutants and wild types was determined by student T-test.

Immunohistochemistry of embryonic ovaries
Ovaries were embedded in agarose and paraffin using standard histology procedure and
sectioned Sµm thick and mounted on glass slides. Slides were then deparaffinized and
thoroughly washed in TBST. Slides were boiled in 10 mM sodium citrate for 10 minutes
and washed in TBST. Addition of the Nobox primary monoclonal IgG goat antibody was
added for 1 hour and was followed by incubation with fluorophore-conjugated polyclonal
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IgG anti-goat secondary antibody for 1 hour (Rajikovic et al, 2004). Then Vector VIP
purple substrate solution (Vector labs) was applied to each slide and incubated for 3
minutes. Slides were then rinsed, dehydrated and visualized at 40X using an Olympus
BX40 microscope.

Detection of AP-2y mutant gametes
Four ERTM-Cre knockout females were mated to wild-type males, and four ERTM-Cre
knockout males were mated to wild-type females. Both were bred at 60, 90, and 130 days
after the last tamoxifen injection.

Dissections
ERTM-Cre mutant ovaries were dissected at 30, 60, and 190 days after the last injection.
Males were dissected 200 days after last injection of tamoxifen and 1 hr after last
injection of BrdU
One ovary or testis from each animal was washed in phosphate-buffered saline and then
fixed in 10% neutral buffered formalin for 12-48 hours and processed using standard
paraffin for histology.
The other teste or ovary was washed in phosphate-buffered saline and then used for RNA
extraction . Tail samples from each mouse were collected in lysis buffer containing
proteinase K for genotype verification .
Sox2-Cre mutant embryos were dissected 18.5 days post coitus (dpc). Ovaries were
washed in phosphate-buffered saline and fixed in 10% neutral buffered formalin for 1248 hours and then processed using standard paraffin for histology. Tail samples from
each embryo were collected and put in lysis buffer containing proteinase K for
genotyping.
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Detection of AP-2y mRNA transcripts
Total RNA was collected and extracted from AP-2y mutant mice and WT mice
using the RNea sy isolation kit according to manufacturer 's specifications (Qiagen, Santa
Clarita, Ca). RNA samp les were quanitated using Eppendorf BioPhotometer.(Eppendorf
AG, Hamburg) cDNA was then prepared from .8µg of total RNA. RT-PCR reaction s to
detect AP-2y were carried out for 35 cycles (94°C, 40 sec; 67°C, 40 sec; 72°C, 40 sec) in
a buffer containing 25mM MgC12 . For AP-2y transcript detection , RT-PCR primer
sequences were designed to anneal in exons 6 and 7 of the AP-2y gene, producing a 206
bp band from the WT allele . This primer set was also used to confirm complete deletion.
These primers would not amplify AP-2y null or AP-2y floxed deleted alleles but would
amplify WT and AP-2y floxed allele s. These primers were used to ensure that the AP-2y
mutant animals we created did not show the presence of AP-2y transcript. Prim er
sequences:

AP-2y floxed primers
AP-2y F- 5' - AAG CGG TGG CTG ACT ATT TAA- 3'
AP-2y R - 5' - CAG GCT GAA ATG AGA CAA ACA G - 3'

RT Real Time PCR to quantitate expression in adult AP-2y mutant ovaries
Ovary samples were taken from adult mice 60 days after last injection with tamoxifen.
RNA was extracted using the RNeasy isolation kit according to manufacturer 's
specifications (Qiagen, Santa Clara, Ca) and quantified using the Eppendorf
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Biophotomenter. Reverse transcription was performed as noted above. Real Time
reactions were prepared to compare AP-2y mRNA levels using Taqman probes (Applied
Biosystems, Foster City, Ca). Reactions were set up according to manufacturer's
specifications and run on a Biorad iCycler (2 min 50°C, 10 min 95°C, Cycle 40 times at
15 sec 95°C and 1 min 60 °C). A standard curve was run with ten fold cDNA dilutions
which were used for quantification and analysis of experimental results.
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RESULTS
Genotypes were verified by

2y null alleles (Fig 4). The

··-·······
234

PCR , for ERTM-Cre and APAP -2y

Null

mice that contained correct

5

••

6

-·7 -

If

8

9

---

CRE

allele combination were

KO

KO

injected with tamoxifen and
deletion of AP-2y was
verified by PCR (Fig. 5).

Figure 4,AP-2y deletion does not affect folliculogenesis

To determine if the ERTM-Cre deletion was complete, RT-PCR was run, which detected
AP-2y expression in ERTM-CRE mutant mice
(Fig 6). The RT-PCR shows a decrease in

KO

WT

KO

KO

expression, but it is not quantifiable, therefore
Real time RT-PCR (qRT-PCR) was run and
confirmed that AP-2y mRNA levels were 60%
of WT after injection with tamoxifen

Figure 5. Verification of AP-2y floxed
deleted alleles after injection with tamoxifen
(lower band) . WT lack Cre allele, therefore
AP-2y is not deleted, and AP-2y is shown with
all exons present (higher band). Product sizes:
I 030 bp and 250 bp
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Adult mice
KO

WT

Figure 6, RT-PCR detection of
AP-2ytranscripts in AP-2y mutant
ovaries and WT ovaries . Product
size 206 bp
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Figure 7, qRT-PCR detection of AP-2y. AP-2y expression was reduced to 60% in the ERTM-Cre
mutant mice (KO) compared to wild-types (WT) .
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Female s were able to produce oocytes after ERTM-Cre TM induced mutation . The
mutant ovarie s looked morphologically similar to wild-types (Fig 8).

KO

WT

Figure 8, ovary sections stained with hemotoxyln and Eosin show that AP-2y
mutants produce oocytes.

Oocyte number s were not different in mutant ovarie s at 30, 60, and 190 day s after TM
injecti on (Table 1).
Table 1, Oocyte numbers in AP-2y mutant ovaries

Days post
injection

KO

WT

Significance

30

2.0 ± 1.4

10.5 ± 0.7

ND

60

8.3 ±2.7

17.6 ± 3.9

P=0.12

190

~.7 ±0.9

6.0 ± 2.1

P=0.43
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Four knockout females were mated to wildtype males and had a total of 24 pups. Out of
24 pups, 14 did not have the CRE allele, and out of the 14 pups without CRE, 4 pups had
the AP-2y-deleted allele, and 5 pups had the AP-2y null allele. Pups with deleted AP-2y
allele indicates that deleted oocytes can produce viable offspring. In addition, out of the
14 that did not have Cre allele, 5 pups had the floxed AP-2y allele which shows
incomplete recombinase activity in the ovary (Table 2).

Table 2, Genotypes of pups from ERTM-Cre TM induced female mice bred to WT male
mice.

wt/Gamflox

wt/AP-2y
null

wt/
Gamflox
deleted

Total# of
offspring

Day 60

2

1

1

4

Day 90

0

1

0

1

Day 130

3

3

3

9
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AP-2y does not affect spermatogenesis

The testes sectio ns looked morphologic ally similar between mutant and wild type testes.
The mutant mice had semi niferou s tubule s and spermatozoa production . (Fig 9).

KO

WT

Figure 9, mutant testes morphologicall y similar to WT testes. Sections of teste stained
with hemotoxyln and Eosin

Immunohistochemisty detection of sper mato gon ia using BrdU (Fig 10) showed
that the number of spermatogonia between AP-2y null and wild-type mice looked
similar.
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KO

WT

Figure 10, Detection of proliferating cells (brown ) using BRDU. Mutant males have ge rmline stem ce lls.

Four knockout male s were mated to wild type females. There were a total of IO1 pups .
Out of 101 pups, 53 did not have Cre allel e, and out of the 53 without Cre, 25 pup s had
AP-2y deleted alle le, zero pups had the AP-2y floxed allele, and 28 pups had the AP-2y

null allele (Table 3). The se results show that sperm are still viable even after AP-2y allele
has been deleted . It also shows that there is comp lete recombinase activity in male
gonads becau se none of the pups had AP-2y floxed allele.
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Table 3, Genotypes of pups from ERTM-Cr e TM induced male mice bred to WT female mice.

wt/Gamflox

wt/AP-2y null

Wt
Gamflox deleted

Total# of
offspring

Day
60

0

6

7

13

Day 90

0

9

7

16

Day
130

0

13

11
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This data shows that AP-2y deletion in adults can still produce viable oocytes and
spermatazoa. However, this does not explain the More-Cre pre ovarian failure. The loss
of oocytes in our More-Cre is probably due to AP-2y deletion during germ line
development in the embryo (More-Cre turns on at E6.5). Therefore, to study the role of
AP-2y during primord ial germ cell deve lopment, we mutated AP-2y in the epiblast using
Sox2-Cre.

22

AP-2y plays a role during primordial germline development

PCR used to detect Sox2-Cre and AP-2y null genotypes.
The complete deletion in the Sox2-Cre model was verified by RT-PCR (Fig 11).
E16.5 embryos

ko

WT

AP-2-y

~-actin

Figure 11, Detection of AP-2y gene
expression. Full deletion of all AP-2y mRNA
transcripts was verified by performing RT-PCR
on RNA samp les of AP-2y WT and AP-2y null
embryos . Product size 200 bp
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Histology on 18.5 mutant ovarie s illu strate s that Sox2 -Cre mutant s have a germ cell
phenotype (Fig 12). Fetal ovarie s collected from El8.5 mutant embryo s fail to produce
any cell s that contain the germ cell marker protein , Nobox .

WT

KO

..
Figure 12, Detection of germ cells in the ovary at E18.5.
Nobox pr ote in detec ted by immun ohistoc he mistry is show n by
purpl e co lor. AP-2y mut ant o n the right shows a lac k of Nobox
pos itive ce lls in the ova ry co mpare d to the litterm ate co nt ro l
(WT ) on the le ft.
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Discussion
AP-2y transcripts were still expressed in female gonads after injection with TM, which
complicates the ERTM-Cre model for studying gene mutations in the ovary. However,
this result did not effect the conclusion that AP-2y does not play a role during
folliculogenesis in adults, because AP-2y deleted oocytes were still able to produce viable
offspring. In addition, the number of oocytes was not significantly different between AP2y deleted ovaries and wild-type ovaries.
AP-2y deletion was complete in male gonads. This was shown when we bred ERTM-Cre
mutant males to wild-type females , and none of their pups carried an undeleted AP-2y
floxed allele. In addition, AP-2y does not affect spermatogenesis, because AP-2y deleted
spermatozoa were able to produce viable offspring. AP-2y deletion does not affect the
rate of sperm production . Spermatogonia are germ line stem cells that will proliferate and
differentiate into spermatozoa . Decreased number of spermatogonia will decrease number
of spermatozoa produced . BrdU stained spermatogonia within the male gonad, and the
number of spermatogonia were no different between mutants and wild-types. Overall,
AP-2y does not play a role in maintaining folliculogenesis and spermatogenesis in adults.
Interestingly through our data, supports a role for AP-2y in regulating germ cell
development during embryonic gonad formation in the mouse. lmmunohistochemistry

of

embryonic fetuses lacked Nobox, which is an oocyte-specific homeobox gene expressed
in germ cell cysts and in primordial and growing oocytes. (Rajkovic et al., 2004). Nobox
is essential for postnatal follicle development. Lack of Nobox expression was presumably
due to loss of PGCs which was due to deletion of AP-2y in the fetal ovary.
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More-Cre AP-2y null mice had a decrease in the number of follicles, and only oocytes
that had expression of AP-2y ever developed into ovulated follicles needed for
reproduction . The More-Cre phenomenon is due to the deletion occurring during
development of gonads, however, an incomplete deletion causes a decrease in infertility
rather than complete infertility at puberty. Our data confirm that transcription factor AP2y is needed for fertility during embryonic development.
AP-2y transcription factor regulates genes needed for fertility. Identifying how AP-2y is
involved in the molecular pathways of reproductive success will be useful. It will allow
people to diagnose unsolved cases of infertility, discover treatments, and preventative
methods in animals as well as humans .
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